Bleomycin

Pediatric Classical Hodgkin Lymphoma Consortium Study: cHOD17

Brentuximab Vedotin in Early Stage Hodgkin Lymphoma

A Frontline Therapy Trial in Participants With Advanced Classical Hodgkin Lymphoma

Safety and Efficacy of Pembrolizumab (MK-3475) in Children and Young Adults With Classical Hodgkin Lymphoma (MK-3475-667/KEYNOTE-667)

A(B)VD Followed by Nivolumab as Frontline Therapy for Higher Risk Patients With Classical Hodgkin Lymphoma (HL)

Injection Sclerotherapy With Bleomycin VS Doxycycline in Patients With Lymphatic Malformations

Investigating Cardiovascular Adverse Events Related to Cancer Treatment

FIL Study on ABVD DD-DI as Upfront Therapy in HL.

Paclitaxel, Ifosfamide and Cisplatin (TIP) Versus Bleomycin, Etoposide and Cisplatin (BEP) for Patients With Previously Untreated Intermediate- and Poor-risk Germ Cell Tumors

Microneedling Alone Versus Microneedling Coupled With Either Bleomycin or 5flourouracil in the Treatment of Plantar Warts

Study of Safety and Efficacy of Pembrolizumab and Chemotherapy in Participants With Newly Diagnosed Classical Hodgkin Lymphoma (cHL) (MK-3475-C11/KEYNOTE-C11)

The Effect of Reduced Bleomycin in Electrochemotherapy Treatment

GISEL:Registry of Breast Cancer Patients Treated With ECT

Brentuximab Vedotin and Nivolumab in Treating Patients With Early Stage Classic Hodgkin Lymphoma

Treatment of Low-flow Venous Malformations With Electrosclerotherapy. Prospective Observational Study

First Line Chemotherapy for Classical Hodgkin Lymphoma in Russia (HL-Russia-1)

Use of Bleomycin in the Sclerotherapy of Lymphatic Malformations for Pediatric Patients

HD21 for Advanced Stages

Compare Two Different Sclerosing Agents in the Treatment of Venous Malformations

Chemotherapy With Low-Dose Radiation for Pediatric Hodgkin Lymphoma